Cargando…

(13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application

Assessment of the liver function, and the need of constant monitoring of the organ's capacity, concerns not only patients with primary liver diseases, but also those at risk of hepatopathies secondary to other chronic diseases. Most commonly, the diagnostics is based on measurements of static b...

Descripción completa

Detalles Bibliográficos
Autores principales: Gorowska-Kowolik, Katarzyna, Chobot, Agata, Kwiecien, Jaroslaw
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516731/
https://www.ncbi.nlm.nih.gov/pubmed/28757868
http://dx.doi.org/10.1155/2017/7397840
_version_ 1783251214462353408
author Gorowska-Kowolik, Katarzyna
Chobot, Agata
Kwiecien, Jaroslaw
author_facet Gorowska-Kowolik, Katarzyna
Chobot, Agata
Kwiecien, Jaroslaw
author_sort Gorowska-Kowolik, Katarzyna
collection PubMed
description Assessment of the liver function, and the need of constant monitoring of the organ's capacity, concerns not only patients with primary liver diseases, but also those at risk of hepatopathies secondary to other chronic diseases. Most commonly, the diagnostics is based on measurements of static biochemical parameters, which allow us to draw conclusions only indirectly about the function and the degree of damage of the organ. On the other hand, liver biopsy is an invasive procedure and therefore it is associated with a considerable risk of complications. Dynamic tests enable us to assess quantitatively the organ's functional reserve by analyzing the kinetics of the metabolization of the substrate by the liver. In practice applied are breath tests using substances such as aminopyrine, caffeine, methacetin, erythromycin (for assessment of the microsomal function); phenylalanine, galactose (for assessment of the cytosolic function); methionine, octanoate, ketoisocaproic acid (for assessment of the mitochondrial function). The test with (13)C methacetin belongs to the best described and most widely applied methods in noninvasive liver function assessment. Due to the rising availability of this method, knowledge concerning its limitations and controversies regarding the methodology, as well as its usefulness in chosen groups of patients, seems to be vital.
format Online
Article
Text
id pubmed-5516731
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-55167312017-07-30 (13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application Gorowska-Kowolik, Katarzyna Chobot, Agata Kwiecien, Jaroslaw Gastroenterol Res Pract Review Article Assessment of the liver function, and the need of constant monitoring of the organ's capacity, concerns not only patients with primary liver diseases, but also those at risk of hepatopathies secondary to other chronic diseases. Most commonly, the diagnostics is based on measurements of static biochemical parameters, which allow us to draw conclusions only indirectly about the function and the degree of damage of the organ. On the other hand, liver biopsy is an invasive procedure and therefore it is associated with a considerable risk of complications. Dynamic tests enable us to assess quantitatively the organ's functional reserve by analyzing the kinetics of the metabolization of the substrate by the liver. In practice applied are breath tests using substances such as aminopyrine, caffeine, methacetin, erythromycin (for assessment of the microsomal function); phenylalanine, galactose (for assessment of the cytosolic function); methionine, octanoate, ketoisocaproic acid (for assessment of the mitochondrial function). The test with (13)C methacetin belongs to the best described and most widely applied methods in noninvasive liver function assessment. Due to the rising availability of this method, knowledge concerning its limitations and controversies regarding the methodology, as well as its usefulness in chosen groups of patients, seems to be vital. Hindawi 2017 2017-07-05 /pmc/articles/PMC5516731/ /pubmed/28757868 http://dx.doi.org/10.1155/2017/7397840 Text en Copyright © 2017 Katarzyna Gorowska-Kowolik et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Gorowska-Kowolik, Katarzyna
Chobot, Agata
Kwiecien, Jaroslaw
(13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
title (13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
title_full (13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
title_fullStr (13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
title_full_unstemmed (13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
title_short (13)C Methacetin Breath Test for Assessment of Microsomal Liver Function: Methodology and Clinical Application
title_sort (13)c methacetin breath test for assessment of microsomal liver function: methodology and clinical application
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5516731/
https://www.ncbi.nlm.nih.gov/pubmed/28757868
http://dx.doi.org/10.1155/2017/7397840
work_keys_str_mv AT gorowskakowolikkatarzyna 13cmethacetinbreathtestforassessmentofmicrosomalliverfunctionmethodologyandclinicalapplication
AT chobotagata 13cmethacetinbreathtestforassessmentofmicrosomalliverfunctionmethodologyandclinicalapplication
AT kwiecienjaroslaw 13cmethacetinbreathtestforassessmentofmicrosomalliverfunctionmethodologyandclinicalapplication